Protective effect of atorvastatin on oxidative stress in streptozotocin‐induced diabetic rats independently their lipid‐lowering effects-Reference-Cited by-同舟云学术

Protective effect of atorvastatin on oxidative stress in streptozotocin‐induced diabetic rats independently their lipid‐lowering effects

Published:2019-01-18 Issue:5 Volume:33 Page:e22295
ISSN:1095-6670
Container-title:Journal of Biochemical and Molecular Toxicology
language:en
Short-container-title:J Biochem Mol Toxicol

Author:

Aktay Göknur¹,Gürsoy Şule Öner¹,Uyumlu Umut¹,Ünüvar Songül²^ORCID,İlhan Nevin³

Affiliation:

1. Department of PharmacologyFaculty of Pharmacy, İnönü UniversityMalatya Turkey

2. Department of Pharmaceutical ToxicologyFaculty of Pharmacy, İnönü UniversityMalatya Turkey

3. Department of BiochemistryFaculty of Medicine, Fırat UniversityElazığ Turkey

Funder

Inönü University Scientific Research Projects Department

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Toxicology,Molecular Biology,Molecular Medicine,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jbt.22295

Reference39 articles.

1. World Health Organization (WHO) Global Report on Diabetes Geneva Switzerland 2016.http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf?ua=1

2. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus

3. Complications of Type 1 Diabetes

4. Standards of Medical Care in Diabetes—2017 Abridged for Primary Care Providers

5. Use of Statins in Patients with Chronic Liver Disease and Cirrhosis: Current Views and Prospects

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A pharmacovigilance study of chronic kidney disease in diabetes mellitus patients with statin treatment by using the US Food and Drug Administration adverse event reporting system;Frontiers in Pharmacology;2024-06-21

2. Effect of beta-glucan on oxidative stress, inflammation, hormonal and histopathological changes in dehydroepiandrosterone-induced polycystic ovary syndrome;2024-06-03

3. Statin initiation and risk of incident kidney disease in patients with diabetes;Canadian Medical Association Journal;2023-05-28

4. Atorvastatin ameliorates lipid overload-induced mitochondrial dysfunction and myocardial hypertrophy by decreasing fatty acid oxidation through inactivation of the p-STAT3/CPT1 pathway;Biomedicine & Pharmacotherapy;2023-01

5. Impact of atorvastatin on plasma and cardiac biomarkers of inflammation, oxidative stress, and fibrosis in a rat model of streptozotocin-induced diabetes;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-10-29